Abstract
We hypothesized that selective control of ventricular contractility might be mediated by postganglionic parasympathetic neurons in the cranial medial ventricular (CMV) ganglion plexus located in a fat pad at the base of the aorta. Sinus rate, atrioventricular (AV) conduction (ventricular rate during atrial pacing), and left ventricular contractile force (LV d P/d t during right ventricular pacing) were measured in eight chloralose-anesthetized dogs both before and during bilateral cervical vagus stimulation (20–30 V, 0.5 ms pulses, 15–20 Hz). Seven of these dogs were tested under beta-adrenergic blockade (propranolol, 0.8 mg kg −1 i.v.). Control responses included sinus node bradycardia or arrest during spontaneous rhythm, high grade AV block or complete heart block, and a 30% decrease in contractility from 2118±186 to 1526±187 mm Hg s −1 ( P<0.05). Next, the ganglionic blocker trimethaphan (0.3–1.0 ml of a 50 μg ml −1 solution) was injected into the CMV fat pad. Then vagal stimulation was repeated, which now produced a relatively small 5% (N.S., P>0.05) decrease in contractility but still elicited the same degree of sinus bradycardia and AV block ( N=8, P<0.05). Five dogs were re-tested 3 h after trimethaphan fat pad injection, at which time blockade of vagally-induced negative inotropy was partially reversed, as vagal stimulation decreased LV d P/d t by 19%. The same dose of trimethaphan given either locally into other fat pads (PVFP or IVC-ILA) or systemically (i.v.) had no effect on vagally-induced negative inotropy. Thus, parasympathetic ganglia located in the CMV fat pad mediated a decrease in ventricular contractility during vagal stimulation. Blockade of the CMV fat pad had no effect on vagally-mediated slowing of sinus rate or AV conduction.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have